204 related articles for article (PubMed ID: 11345717)
1. Proton magnetic resonance chemical shift imaging (1H CSI)-directed stereotactic biopsy.
Son BC; Kim MC; Choi BG; Kim EN; Baik HM; Choe BY; Naruse S; Kang JK
Acta Neurochir (Wien); 2001; 143(1):45-9; discussion 49-50. PubMed ID: 11345717
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of proton chemical shift imaging with a stereotactic headframe.
Baik HM; Choe BY; Son BC; Kim MC; Kim EN; Lee HK; Suh TS
Magn Reson Imaging; 2003 Jan; 21(1):55-9. PubMed ID: 12620547
[TBL] [Abstract][Full Text] [Related]
3. Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement.
Widhalm G; Krssak M; Minchev G; Wöhrer A; Traub-Weidinger T; Czech T; Asenbaum S; Marosi C; Knosp E; Hainfellner JA; Prayer D; Wolfsberger S
J Neurol Neurosurg Psychiatry; 2011 May; 82(5):512-20. PubMed ID: 20971752
[TBL] [Abstract][Full Text] [Related]
4. Proton MR spectroscopy in patients with complex partial seizures: single-voxel spectroscopy versus chemical-shift imaging.
Hsu YY; Chang C; Chang CN; Chu NS; Lim KE; Hsu JC
AJNR Am J Neuroradiol; 1999 Apr; 20(4):643-51. PubMed ID: 10319976
[TBL] [Abstract][Full Text] [Related]
5. An efficient chemical shift imaging scheme for magnetic resonance-guided neurosurgery.
Liu H; Hall WA; Martin AJ; Truwit CL
J Magn Reson Imaging; 2001 Jul; 14(1):1-7. PubMed ID: 11436207
[TBL] [Abstract][Full Text] [Related]
6. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
7. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
[TBL] [Abstract][Full Text] [Related]
8. Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.
Bradac O; Vrana J; Jiru F; Kramar F; Netuka D; Hrabal P; Horinek D; de Lacy P; Benes V
Br J Neurosurg; 2014 Oct; 28(5):631-6. PubMed ID: 24377726
[TBL] [Abstract][Full Text] [Related]
9. MR spectroscopy in gliomatosis cerebri.
Bendszus M; Warmuth-Metz M; Klein R; Burger R; Schichor C; Tonn JC; Solymosi L
AJNR Am J Neuroradiol; 2000 Feb; 21(2):375-80. PubMed ID: 10696026
[TBL] [Abstract][Full Text] [Related]
10. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
11. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
Zonari P; Baraldi P; Crisi G
Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
[TBL] [Abstract][Full Text] [Related]
12. Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy.
Ng WH; Lim T
J Clin Neurosci; 2008 May; 15(5):502-6. PubMed ID: 18334298
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.
Kimura T; Sako K; Tanaka K; Gotoh T; Yoshida H; Aburano T; Tanaka T; Arai H; Nakada T
J Neurosurg; 2004 May; 100(5):835-41. PubMed ID: 15137602
[TBL] [Abstract][Full Text] [Related]
14. Early metabolic changes in metastatic brain tumors after Gamma Knife radiosurgery: 1H-MRS study.
Chernov MF; Hayashi M; Izawa M; Abe K; Usukura M; Ono Y; Kubo O; Hori T
Brain Tumor Pathol; 2004; 21(2):63-7. PubMed ID: 15700835
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density.
Ganslandt O; Stadlbauer A; Fahlbusch R; Kamada K; Buslei R; Blumcke I; Moser E; Nimsky C
Neurosurgery; 2005 Apr; 56(2 Suppl):291-8; discussion 291-8. PubMed ID: 15794826
[TBL] [Abstract][Full Text] [Related]
16. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
17. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
Likavcanová K; Dobrota D; Liptaj T; Prónayová N; Mlynárik V; Belan V; Galanda M; Béres A; De Riggo J
Gen Physiol Biophys; 2005 Sep; 24(3):327-35. PubMed ID: 16308427
[TBL] [Abstract][Full Text] [Related]
18. Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemotherapy.
Balmaceda C; Critchell D; Mao X; Cheung K; Pannullo S; DeLaPaz RL; Shungu DC
J Neurooncol; 2006 Jan; 76(2):185-91. PubMed ID: 16151595
[TBL] [Abstract][Full Text] [Related]
19. The utility of magnetic resonance spectroscopy in frame-less stereotactic needle biopsy of glioma.
Wang Q; Zhang J; Li F; Chen X; Xu B
J Clin Neurosci; 2021 Jun; 88():102-107. PubMed ID: 33992167
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
